Top Markets
Coin of the day
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Kedudukan dalam Saham #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Harga Saham
$0.00023723
Disegerakkan terakhir: 2024-08-26
Modal Pasaran
$1.41K
Perubahan (1 hari)
111.67%
Perubahan (1 tahun)
0.00%
Negara
FR
Perdagangan Pharnext S.A. (ALPHA)

Kategori

Sejarah dividen untuk Pharnext S.A. (ALPHA)
Pharnext S.A. (simbol saham: ALPHA) telah membuat sejumlah 1 pembayaran dividen.
Jumlah semua dividen (disesuaikan untuk pemecahan saham): $0.20
Hasil dividen (TTM): 0
Pembayaran dividen untuk Pharnext S.A. (ALPHA) dari 2024 hingga 2026
Pembayaran dividen tahunan
Tahun Dividen (diselaraskan untuk pemecahan saham) Ubah
2026 (TTM) $0.2 0.00%
2024 $0.2 0.00%
Senarai semua pembayaran dividen
Tahun Dividen Ubah
2026 (TTM) $0.2 0.00%
2024 $0.2 0.00%
Pembayaran dividen untuk syarikat serupa atau pesaing
Syarikat Jumlah pembayaran dividen Negara
0.00%
US
0.00%
NL
0.00%
CH
29.00%
BE
0.00%
KR